At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...

The inoculation, produced by the Butantan Institute in partnership with Austrian Valneva, had its registration approved this ...

It makes sense to include routine adult vaccinations to our list of preventative measures, not only for prevention of common ...

The vaccine for varicella-zoster virus, commonly known as shingles, could do far more than just protecting people from a rash ...

The vaccine for varicella-zoster virus, commonly known as shingles, could do far more than just protecting people from a rash ...

The shingles vaccine, typically administered to fend off a painful rash, might pack an unexpected benefit by delaying or even ...

A recent study found that people who received Zostavax, a older shingles vaccine, had a lower risk of developing dementia.

The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...

The global influenza vaccine market, valued at US$ 8.78 billion in 2023, is poised for remarkable growth, with projections indicating it will reach US$ 22.71 billion by 2032. This growth, representing ...

Recent estimates suggest that about 7.4% of adults over 60 or 88 lakh people are living with dementia in India.

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...

The Asia Pacific Preventive Vaccines Market is experiencing a transformative surge, with its valuation leaping from USD 20.9 billion in 2023 to a projected USD 63.11 billion by 2032, growing at a ...